13F HOLDINGS REPORT
Stonepine Capital Management, LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0000935836-23-000233
Total Value
$237.7M
Positions
19
Other Managers
0
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AMRYT PHARMA PLC - SPNR ADR | 03217L106 | 6,333,239 | $46.2M | 19.45% |
| 2 | APOLLO ENDOSURGERY INC | 03767D108 | 3,726,584 | $37.2M | 15.63% |
| 3 | CTI BIOPHARMA CORP | 12648L601 | 4,934,100 | $29.7M | 12.47% |
| 4 | ADMA BIOLOGICS INC | ADMA | 6,940,000 | $26.9M | 11.33% |
| 5 | QUIDELORTHO CORP | QDEL | 300,000 | $25.7M | 10.81% |
| 6 | XERIS BIOPHARMA HOLDINGS INC | XERS | 11,195,189 | $14.9M | 6.26% |
| 7 | UROGEN PHARMA LTD | URGN | 1,304,947 | $11.6M | 4.87% |
| 8 | THIRD HARMONIC BIO INC | 88427A107 | 2,015,301 | $8.7M | 3.65% |
| 9 | GALAPAGOS NV-SPON ADR | GLPGF | 194,836 | $8.6M | 3.64% |
| 10 | EVOLUS INC | EOLS | 834,432 | $6.3M | 2.64% |
| 11 | REZOLUTE INC | RZLT | 3,021,504 | $6.3M | 2.63% |
| 12 | CASTLE BIOSCIENCES INC | CSTL | 178,240 | $4.2M | 1.77% |
| 13 | CONFORMIS INC | 20717E101 | 748,194 | $2.5M | 1.04% |
| 14 | MIRUM PHARMACEUTICALS INC | MIRM | 108,769 | $2.1M | 0.89% |
| 15 | EXAGEN INC | XGN | 854,042 | $2.0M | 0.86% |
| 16 | MAXCYTE INC | MXCT | 273,287 | $1.5M | 0.63% |
| 17 | OMNIAB INC | OABIW | 354,266 | $1.3M | 0.54% |
| 18 | XOMA CORP | XOMAP | 64,459 | $1.2M | 0.50% |
| 19 | OPTINOSE INC | 68404V100 | 508,284 | $940,325 | 0.40% |